Collin Melveton Stultz, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Folding | 16 | 2017 | 840 | 1.740 |
Why?
|
| Protein Conformation | 23 | 2016 | 4010 | 1.570 |
Why?
|
| Thermodynamics | 15 | 2016 | 594 | 1.480 |
Why?
|
| Molecular Dynamics Simulation | 8 | 2017 | 409 | 1.320 |
Why?
|
| Models, Molecular | 26 | 2016 | 5451 | 1.140 |
Why?
|
| Protein Structure, Secondary | 14 | 2019 | 1247 | 0.990 |
Why?
|
| Collagen | 6 | 2010 | 2688 | 0.980 |
Why?
|
| Collagen Type I | 3 | 2013 | 592 | 0.900 |
Why?
|
| Collagenases | 3 | 2010 | 228 | 0.850 |
Why?
|
| Acute Coronary Syndrome | 6 | 2019 | 2337 | 0.820 |
Why?
|
| Aortic Valve Stenosis | 2 | 2022 | 1965 | 0.710 |
Why?
|
| Proteins | 8 | 2014 | 6100 | 0.690 |
Why?
|
| alpha-Synuclein | 4 | 2013 | 722 | 0.670 |
Why?
|
| Long QT Syndrome | 1 | 2023 | 453 | 0.660 |
Why?
|
| Peptide Fragments | 6 | 2014 | 5096 | 0.580 |
Why?
|
| Antitoxins | 1 | 2017 | 81 | 0.570 |
Why?
|
| Electrocardiography | 7 | 2023 | 6442 | 0.570 |
Why?
|
| Collagen Type III | 2 | 2010 | 90 | 0.560 |
Why?
|
| Colicins | 1 | 2016 | 15 | 0.560 |
Why?
|
| tau Proteins | 4 | 2012 | 1868 | 0.560 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2016 | 92 | 0.540 |
Why?
|
| CREB-Binding Protein | 1 | 2016 | 151 | 0.530 |
Why?
|
| Amyloidogenic Proteins | 1 | 2016 | 152 | 0.510 |
Why?
|
| Models, Chemical | 2 | 2016 | 626 | 0.500 |
Why?
|
| Escherichia coli Proteins | 6 | 2019 | 1050 | 0.490 |
Why?
|
| Microfibrils | 1 | 2013 | 17 | 0.450 |
Why?
|
| Computers | 1 | 2016 | 612 | 0.450 |
Why?
|
| Heart Valve Prosthesis | 1 | 2022 | 1490 | 0.450 |
Why?
|
| Cardiovascular System | 1 | 2020 | 831 | 0.450 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2013 | 56 | 0.440 |
Why?
|
| Nickel | 2 | 2010 | 130 | 0.420 |
Why?
|
| Molecular Biology | 1 | 2016 | 596 | 0.410 |
Why?
|
| Bayes Theorem | 4 | 2016 | 2307 | 0.400 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2022 | 1537 | 0.390 |
Why?
|
| Protein Multimerization | 5 | 2014 | 971 | 0.380 |
Why?
|
| Amyloid beta-Peptides | 2 | 2014 | 3587 | 0.380 |
Why?
|
| Amino Acid Sequence | 12 | 2019 | 13814 | 0.360 |
Why?
|
| Protein Unfolding | 5 | 2013 | 54 | 0.360 |
Why?
|
| Disulfides | 1 | 2012 | 457 | 0.360 |
Why?
|
| Amino Acids | 1 | 2016 | 1737 | 0.350 |
Why?
|
| Amyloid | 1 | 2014 | 795 | 0.350 |
Why?
|
| Cardiology | 1 | 2020 | 1668 | 0.340 |
Why?
|
| Solvents | 2 | 2008 | 302 | 0.340 |
Why?
|
| Structure-Activity Relationship | 5 | 2016 | 3130 | 0.330 |
Why?
|
| X-Ray Diffraction | 3 | 2016 | 420 | 0.330 |
Why?
|
| Fibronectins | 2 | 2013 | 726 | 0.330 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2008 | 95 | 0.320 |
Why?
|
| Protein Binding | 10 | 2016 | 9384 | 0.300 |
Why?
|
| Computational Biology | 4 | 2012 | 3519 | 0.290 |
Why?
|
| Hydrogen Bonding | 4 | 2014 | 291 | 0.280 |
Why?
|
| Bacterial Proteins | 2 | 2017 | 3854 | 0.280 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2016 | 475 | 0.270 |
Why?
|
| Models, Biological | 4 | 2017 | 9584 | 0.250 |
Why?
|
| Models, Theoretical | 2 | 2008 | 3589 | 0.250 |
Why?
|
| Molecular Sequence Data | 10 | 2013 | 18111 | 0.250 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 4 | 2013 | 506 | 0.250 |
Why?
|
| Oligopeptides | 2 | 2008 | 1189 | 0.250 |
Why?
|
| Algorithms | 8 | 2020 | 13882 | 0.250 |
Why?
|
| Repressor Proteins | 3 | 2010 | 3024 | 0.240 |
Why?
|
| Scattering, Small Angle | 2 | 2016 | 59 | 0.240 |
Why?
|
| Protein Structure, Tertiary | 7 | 2019 | 3848 | 0.230 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2009 | 1121 | 0.230 |
Why?
|
| Small Molecule Libraries | 1 | 2009 | 720 | 0.230 |
Why?
|
| Escherichia coli | 6 | 2019 | 4217 | 0.220 |
Why?
|
| Ligands | 5 | 2010 | 3282 | 0.220 |
Why?
|
| Circular Dichroism | 4 | 2011 | 354 | 0.210 |
Why?
|
| Aortic Valve | 2 | 2022 | 1924 | 0.210 |
Why?
|
| Risk Assessment | 3 | 2019 | 23336 | 0.200 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2002 | 375 | 0.200 |
Why?
|
| Drug Discovery | 1 | 2009 | 1058 | 0.190 |
Why?
|
| Catalytic Domain | 3 | 2010 | 698 | 0.190 |
Why?
|
| Protein Denaturation | 3 | 2008 | 237 | 0.190 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2023 | 585 | 0.180 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2000 | 129 | 0.180 |
Why?
|
| Neurodegenerative Diseases | 1 | 2009 | 1061 | 0.180 |
Why?
|
| Binding Sites | 8 | 2010 | 6111 | 0.180 |
Why?
|
| Dimerization | 2 | 2013 | 895 | 0.170 |
Why?
|
| RNA | 1 | 2009 | 2749 | 0.170 |
Why?
|
| Heart Failure | 1 | 2023 | 10895 | 0.170 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2023 | 789 | 0.160 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2000 | 311 | 0.160 |
Why?
|
| Acetyltransferases | 1 | 2019 | 234 | 0.160 |
Why?
|
| Molecular Targeted Therapy | 1 | 2009 | 2725 | 0.150 |
Why?
|
| Humans | 33 | 2023 | 744366 | 0.150 |
Why?
|
| Temperature | 3 | 2011 | 2204 | 0.150 |
Why?
|
| Carrier Proteins | 2 | 2010 | 5023 | 0.150 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 4851 | 0.140 |
Why?
|
| Crystallography, X-Ray | 3 | 2010 | 2012 | 0.130 |
Why?
|
| Substrate Specificity | 2 | 2010 | 1802 | 0.130 |
Why?
|
| Peptides | 5 | 2013 | 4410 | 0.130 |
Why?
|
| Protein Structure, Quaternary | 2 | 2019 | 436 | 0.130 |
Why?
|
| Solutions | 1 | 2016 | 426 | 0.130 |
Why?
|
| Kinetics | 3 | 2014 | 6476 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2017 | 6539 | 0.130 |
Why?
|
| Mytilus | 1 | 2014 | 7 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2007 | 2962 | 0.130 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 3707 | 0.130 |
Why?
|
| Hyperglycemia | 1 | 2003 | 1373 | 0.120 |
Why?
|
| Lysine | 2 | 2010 | 1007 | 0.120 |
Why?
|
| Nanofibers | 1 | 2014 | 66 | 0.120 |
Why?
|
| Models, Cardiovascular | 2 | 2017 | 996 | 0.120 |
Why?
|
| Adhesives | 1 | 2014 | 61 | 0.120 |
Why?
|
| Drug Design | 3 | 2009 | 1076 | 0.120 |
Why?
|
| Death | 2 | 2016 | 678 | 0.120 |
Why?
|
| Logistic Models | 2 | 2019 | 13409 | 0.110 |
Why?
|
| Hemodynamics | 1 | 2023 | 4196 | 0.110 |
Why?
|
| Protein Stability | 2 | 2010 | 556 | 0.100 |
Why?
|
| Glucose | 1 | 2003 | 4398 | 0.100 |
Why?
|
| Hemopexin | 1 | 2010 | 33 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2019 | 40559 | 0.090 |
Why?
|
| Operon | 1 | 2010 | 363 | 0.090 |
Why?
|
| Chemical Phenomena | 1 | 2009 | 518 | 0.090 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2016 | 1534 | 0.080 |
Why?
|
| Receptors, Fibronectin | 1 | 2008 | 39 | 0.080 |
Why?
|
| Pliability | 1 | 2008 | 63 | 0.080 |
Why?
|
| Hydroxylation | 1 | 2008 | 141 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 365 | 0.080 |
Why?
|
| Aspartic Acid | 1 | 2010 | 576 | 0.080 |
Why?
|
| Computer Simulation | 3 | 2006 | 6194 | 0.080 |
Why?
|
| Oxygen | 1 | 2019 | 4189 | 0.080 |
Why?
|
| Prognosis | 3 | 2019 | 29060 | 0.070 |
Why?
|
| Tensile Strength | 1 | 2008 | 335 | 0.070 |
Why?
|
| Patient Selection | 1 | 2019 | 4216 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2010 | 1005 | 0.070 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2012 | 1085 | 0.070 |
Why?
|
| Hydrolysis | 1 | 2008 | 682 | 0.070 |
Why?
|
| Microtubules | 2 | 2012 | 1089 | 0.070 |
Why?
|
| Systems Integration | 1 | 2008 | 440 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2012 | 942 | 0.070 |
Why?
|
| Mutant Proteins | 1 | 2008 | 500 | 0.070 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 2184 | 0.070 |
Why?
|
| Chickens | 1 | 2008 | 865 | 0.070 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2014 | 1572 | 0.070 |
Why?
|
| Normal Distribution | 1 | 2006 | 280 | 0.070 |
Why?
|
| Entropy | 1 | 2006 | 209 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 12244 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2012 | 2971 | 0.070 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 937 | 0.070 |
Why?
|
| Heart Rate | 2 | 2014 | 4092 | 0.070 |
Why?
|
| Mutation | 2 | 2010 | 29786 | 0.060 |
Why?
|
| Glutamic Acid | 1 | 2010 | 1169 | 0.060 |
Why?
|
| Models, Statistical | 3 | 2006 | 5101 | 0.060 |
Why?
|
| Lung | 1 | 2023 | 9857 | 0.060 |
Why?
|
| Stroke Volume | 2 | 2014 | 5006 | 0.060 |
Why?
|
| Conservation of Energy Resources | 1 | 2003 | 20 | 0.060 |
Why?
|
| Registries | 1 | 2019 | 8091 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 2839 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2009 | 719 | 0.060 |
Why?
|
| Integrins | 1 | 2008 | 846 | 0.060 |
Why?
|
| Internet | 1 | 2016 | 3056 | 0.060 |
Why?
|
| High-Throughput Screening Assays | 1 | 2009 | 944 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2022 | 5035 | 0.060 |
Why?
|
| Peptide Biosynthesis | 1 | 2002 | 55 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2007 | 1794 | 0.050 |
Why?
|
| Cattle | 1 | 2008 | 3922 | 0.050 |
Why?
|
| Risk Factors | 4 | 2019 | 72296 | 0.050 |
Why?
|
| Rats | 2 | 2013 | 24252 | 0.050 |
Why?
|
| Aged | 5 | 2019 | 163288 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 972 | 0.050 |
Why?
|
| Electroencephalography | 1 | 2016 | 6151 | 0.050 |
Why?
|
| Animals | 7 | 2014 | 168768 | 0.050 |
Why?
|
| Middle Aged | 5 | 2019 | 213390 | 0.050 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2002 | 401 | 0.050 |
Why?
|
| HIV Protease | 1 | 1999 | 96 | 0.040 |
Why?
|
| Methanol | 1 | 1999 | 85 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 12356 | 0.040 |
Why?
|
| DNA | 2 | 2010 | 7294 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2007 | 3616 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 2216 | 0.040 |
Why?
|
| Crystallization | 1 | 1999 | 525 | 0.040 |
Why?
|
| Myocardium | 1 | 2011 | 4772 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2008 | 3749 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 3799 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2009 | 2148 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39052 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2002 | 2256 | 0.040 |
Why?
|
| Male | 6 | 2019 | 350115 | 0.040 |
Why?
|
| Monocytes | 1 | 2007 | 2596 | 0.040 |
Why?
|
| HIV Protease Inhibitors | 1 | 1999 | 430 | 0.040 |
Why?
|
| Female | 6 | 2019 | 380193 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2009 | 10252 | 0.030 |
Why?
|
| Myocardial Infarction | 2 | 2014 | 11718 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 1525 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2000 | 1254 | 0.030 |
Why?
|
| Mathematics | 2 | 1994 | 728 | 0.030 |
Why?
|
| Adhesiveness | 1 | 2014 | 53 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2023 | 77460 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 14723 | 0.030 |
Why?
|
| Flavodoxin | 1 | 1993 | 3 | 0.030 |
Why?
|
| Neurons | 1 | 2012 | 9340 | 0.030 |
Why?
|
| Polymerization | 1 | 2013 | 164 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 407 | 0.030 |
Why?
|
| Thioredoxins | 1 | 1993 | 213 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2002 | 8436 | 0.020 |
Why?
|
| Tryptophan | 1 | 2013 | 478 | 0.020 |
Why?
|
| Probability | 2 | 1994 | 2506 | 0.020 |
Why?
|
| Disaccharides | 1 | 2010 | 171 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2013 | 894 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2010 | 277 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 3759 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2010 | 688 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1993 | 1899 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 15160 | 0.020 |
Why?
|
| Calmodulin | 1 | 2009 | 209 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 40075 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 19905 | 0.020 |
Why?
|
| Software | 1 | 2002 | 4441 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2009 | 285 | 0.020 |
Why?
|
| Water | 1 | 2014 | 1395 | 0.020 |
Why?
|
| Glycosylation | 1 | 2010 | 1128 | 0.020 |
Why?
|
| Placebos | 1 | 2011 | 1676 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2014 | 3773 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2006 | 8038 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 1741 | 0.020 |
Why?
|
| Survival Rate | 2 | 2009 | 12788 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2013 | 4162 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15078 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2011 | 5984 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2013 | 19233 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2012 | 14561 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 7914 | 0.010 |
Why?
|
| Calcium | 1 | 2009 | 5755 | 0.010 |
Why?
|
| Models, Structural | 1 | 1994 | 361 | 0.010 |
Why?
|
| Markov Chains | 1 | 1994 | 969 | 0.010 |
Why?
|
| Mice | 1 | 2012 | 81201 | 0.000 |
Why?
|